Imaging tests can help spot nasopharyngeal cancer or determine if it has spread. Imaging tests may include: Chest X-ray; ... Nasopharyngeal cancer is staged from Stage 0 ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...

The common malignant lesions in this region include esthesioneuroblastoma, nasopharyngeal carcinoma, neuroendocrine carcinoma, rhabdomyosarcoma, lymphoepithelioma, lymphoma, melanoma and poorly ...

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma. A. D. King and others. Annals of Oncology, 2019. Volume 30, Pahes 977–982. The Evolving ...

Nasopharyngeal carcinoma of the undifferentiated histologic subtype is endemic and prevalent in southeast Asia. The dramatic improvement of treatment outcomes and overall prognosis during the past few ...

Nasopharyngeal cancer may cause signs like: Swelling or lump in your neck that doesn’t go away; ... Imaging tests. Scans of your neck can show if you have cancer and if it’s spread.

Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China, and patient prognosis has improved significantly over the past three decades because of advances in disease ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and CD70 ...